Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
Wiegand
Johannes
J
Patel
Keyur
K
Tillmann
Hans L
HL
D000465:Algorithms; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D016896:Treatment Outcome
D000998:Antiviral Agents; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens